Current first-line antidepressant therapies, which primarily target monoaminergic neurotransmitter systems, demonstrate limited efficacy in this patient population
doi: 10.1126/scisignal.adx6752, 211 WadhwaS.JainS.PatilN.JungadeS
Additionally, it can provide an energy boost and reduce fatigue, which can be beneficial during a weight loss journey
BPC-157 activates vascular endothelial growth factor receptor 2 (VEGFR2), which triggers nitric oxide synthesis through the Akt-eNOS axis
Benefits include: Reduced hunger and cravings (food noise) Improved portion control Weekly injections Physician-supervised treatment Personalized weight loss plans Long-term weight managment support WHAT DO SEMAGLUTIDE INJECTIONS FEEL LIKE
Clinical trials have shown meaningful weight loss compared with placebo, and the daily pill format is easier to integrate into your daily routine (GLP-1 drugs that require injection have been a major barrier for many patients)